Trial intelligence / Profile preview

ADACEL booster immunogenicity vs local DT/Td vaccines in Chinese children, adolescents and adults

CTR20131162Phase 3Active

Sponsor
Sanofi
Start
Apr 2014
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of acellular pertussis vaccine in diphtheria, Tetanus, pertussis, sponsored by Sanofi. Started Apr 2014; status: active.

02

Drugs

acellular pertussis vaccine
03

Conditions

diphtheriaTetanuspertussis

Beyond the preview

Go deeper on CTR20131162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call